Drug Trial Radar · NCT02546583
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
Last checked: Nov 20, 2026Latest source record: Aug 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
458
Actual
Start
Aug 31, 2015
Primary completion
Jan 23, 2020
Study completion Jan 23, 2020
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Sep 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Effective diuresis is the primary goal of most acute decompensated heart failure hospitalizations, but diuretic resistance is common and our ability to detect it is limited. Further, there are therapeutically distinct groups of diuretic-resistant patients. These are not easily distinguished using currently available methods, leading to trial-and-error based treatment that promotes lengthy hospitalizations. The aims of this study are: 1. To develop inexpensive and efficient tools to predict diuretic response 2. To understand the prevalence of therapeutically targetable mechanisms of diuretic resistance using endogenous lithium clearance 3. To develop methodology to differentiate diuretic resistance mechanisms using common/inexpensive laboratory tests 4. To provide proof of concept that mechanistically tailored diuretic therapy can improve natriuresis
Conditions
- Heart Failure
Interventions
Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide)Drug
An increase to 2.5x the Visit 1 dose of loop diuretic (bumetanide or furosemide).
IV ChlorothiazideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accuracy of sodium prediction equation in predicting suboptimal natriuretic response to a dose of diureticsTime frame: 6 hours
- Prevalence of mechanistic sub types of Diuretic Resistance (DR) as defined by cutoff values of change in fractional excretion of lithiumTime frame: 6 hours
- Accuracy of prediction of mechanistic sub types of DR using universally available laboratory testsTime frame: 6 hours
- Change in total 6-hour sodium output between observational and randomized intervention study days, compared between intervention groupsTime frame: 6 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.